Practice
Featured experience
Global Eggs $1.1 billion acquisition of Hillandale Farms
We advised the buyer in connection with this transaction and the related acquisition financing
Strive Asset Management combination with Asset Entities
We are advising Strive on the transaction
TPG and Corpay $2.2 billion acquisition of AvidXchange Holdings
We are advising TPG on the transaction
Airbus acquisition of certain assets and sites from Spirit AeroSystems
We are advising Airbus on the transaction
KPS Capital Partners $2.1 billion acquisition of assets of Garrett Motion
Davis Polk is advising KPS Capital Partners, LP on its acquisition of substantially all of the assets of Garrett Motion Inc…
Orogen Group acquisition of a majority interest in Westcor Land Title Insurance
Davis Polk is advising The Orogen Group on its acquisition of a majority interest in Westcor Land Title Insurance Company…
Murray Energy restructuring consummated
Davis Polk advised an ad hoc group of lenders (the “Ad Hoc Group”) to Murray Energy Corporation (together with certain of…
Spirit Airlines $850 million senior notes offering
Davis Polk advised Spirit Airlines, Inc. in connection with a Rule 144A/Regulation S offering of $850 million aggregate…
Truist strategic funding of Veem
Davis Polk advised Truist Ventures, the corporate venture capital division of Truist Financial Corporation, on its lead role…
MicroStrategy $60.5 million tender offer
Davis Polk advised the dealer manager in connection with a “modified Dutch auction” cash tender offer by MicroStrategy…
Sterling Equities sale of the New York Mets
We advised Sterling Equities on the sale
Gilead Sciences $21 billion acquisition of Immunomedics
Davis Polk is advising Gilead Sciences, Inc. in its acquisition of Immunomedics, Inc. for $88.00 per share in cash. The…
Silver Lake investment in Reliance Industries’ Reliance Retail Ventures
Davis Polk is advising Reliance Industries Limited and Reliance Retail Ventures Limited in connection with Silver Lake’s…
Nestlé $2.6 billion acquisition of Aimmune Therapeutics
Davis Polk is advising JP Morgan Securities LLC and Lazard as financial advisers to Aimmune Therapeutics in connection with…